Study: Wearables Alone not Good Enough for Health Improvement | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Study: Wearables Alone not Good Enough for Health Improvement

October 7, 2016
by Rajiv Leventhal
| Reprints

Although activity trackers continue to grow in popularity, a new study from the Duke-NUS Medical School has found that these trackers are unlikely to help people become more active.

One main reason for this is that that most stop wearing the devices, such as Fitbit, Jawbone, Garmin and others, within a few weeks or months, the researchers found. The study, published in The Lancet Diabetes & Endocrinology, recruited 800 working adults from Singapore and randomly assigned them to a control group, a tracker only group, or tracker plus one of two types of rewards schemes. One reward group accrued rewards in cash and the other had the rewards go to a charity of the individual's choosing.

The researchers assessed physical activity outcomes, including steps and activity bouts, and health outcomes, including weight and blood pressure at study conclusion and after one year, six months after incentives were removed.

Indeed, the findings showed that regardless of physical activity levels of participants before the study began, activity trackers alone or when combined with rewards designated for charity did not increase activity levels. In fact, nearly half of participants were no longer wearing their trackers by the six month assessment period. In contrast, both active and inactive individuals offered cash rewards significantly increased activity levels between baseline and six months and nearly 90 percent continued to wear the trackers.

However, at the end of 12 months, six months after the incentives were removed, this group showed poorer step outcomes than the tracker only group, suggesting that removing the incentives may have demotivated these individuals and caused them to do worse than had the incentives never been offered. Despite the step differences, activity trackers, with or without incentives, did not lead to noticeable improvements in health outcomes.

Lead author of the study, Eric Finkelstein of the Duke-NUS Medical School, noted, "Activity trackers alone are not going to stem the rise in chronic diseases." However, he further said that "they could still be part of a comprehensive solution and there may be a role for low cost incentive strategies, although they would likely have to be permanent to avoid any undermining effect from taking them away."

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

AHRQ Launches App Challenge for PRO Data Standardization

The Agency for Healthcare Research and Quality (AHRQ) has launched a competition to address the need for greater use of standardized patient-reported outcomes (PRO) data in clinical care and research.

Study: Many U.S. Hospitals won’t Reach HIMSS Stage 7 Until 2035

Unless the healthcare IT ecosystem experiences major policy changes or leaps in technological capabilities, many hospitals will not reach Stage 7 of HIMSS Analytics’ Electronic Medical Record Adoption Model until 2035, according to new research.

Amazon, Google, IBM and Other Tech Giants Pledge to Remove Barriers to Interoperability

Six of the world's biggest technology companies, including Microsoft, Google, IBM and Amazon, made a joint pledge at the White House Monday to remove interoperability barriers and to make progress on adoption of health data standards.

Mayo Clinic Elects New President and CEO

Gianrico Farrugia, M.D., current vice president, Mayo Clinic, and CEO of Mayo Clinic in Florida has been elected as the president and CEO of the Mayo Clinic, headquartered in Minnesota.

Fitbit, Blue Cross Blue Shield Launch Mobile Health Partnership

San Francisco-based fitness wearable maker Fitbit continues its push into the health plan market with a new digital health deal to incorporate its fitness tracker into health and wellness programs.

ASCO Picks IBM Watson Exec to Lead CancerLinQ

The American Society of Clinical Oncology (ASCO) has named a former IBM Watson executive as the new CEO of its CancerLinQ big data platform.